Browsing Bergen Open Research Archive by Author "Ingebriktsen, Lise Martine"

Now showing items 1-4 of 4

    • Age-Related Clusters and Favorable Immune Phenotypes in Breast Cancer of the Young Patients 

      Ingebriktsen, Lise Martine; Svanøe, Amalie Abrahamsen; Sæle, Anna Kristine Myrmel; Humlevik, Rasmus Olai Collett; Toska, Karen; Kalvenes, May Britt; Aas, Turid; Heie, Anette; Askeland, Cecilie; Knutsvik, Gøril; Stefansson, Ingunn Marie; Akslen, Lars Andreas; Høivik, Erling André; Wik, Elisabeth (Journal article; Peer reviewed, 2024)
      Breast cancer (BC) patients aged <40 years at diagnosis experience aggressive disease and poorer survival compared with women diagnosed with BC at 40 to 49 years, but the age-related biology is described to little extent. ...

    • Breast cancer of the young: Exploring age-related breast cancer biology 

      Ingebriktsen, Lise Martine (Doctoral thesis, 2023-11-30)
      Brystkreft er en sykdom som i en økende grad rammer kvinner i Norge og den vestlige verden. Brystkreft blant yngre kvinner er også økende, og dessuten assosiert med mer aggressiv tumor type og verre klinisk utfall sammenlignet ...

    • High expression of miR‑17‑5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients 

      Støen, Maria Jenvin; Andersen, Sigve; Rakaee, Mehrdad; Pedersen, Mona Irene; Ingebriktsen, Lise Martine; Bremnes, Roy M.; Dønnem, Tom; Lombardi, Ana Paola; Kilvær, Thomas Karsten; Rasmussen Busund, Lill-Tove; Richardsen, Elin (Journal article; Peer reviewed, 2021)
      MicroRNAs (miRs) are small non-coding RNA molecules, which are involved in the development of various malignancies, including prostate cancer (PCa). miR-17-5p is considered the most prominent member of the miR-17-92 cluster, ...

    • A novel age-related gene expression signature associates with proliferation and disease progression in breast cancer 

      Ingebriktsen, Lise Martine; Finne, Kenneth; Akslen, Lars Andreas; Wik, Elisabeth (Journal article; Peer reviewed, 2022)
      Background and objective Breast cancer (BC) diagnosed at ages <40 years presents with more aggressive tumour phenotypes and poorer clinical outcome compared to older BC patients. Here, we explored transcriptional BC ...